Ferro A - Search Results

1

Learning from organisational changes in the management of breast cancer patients during the COVID-19 pandemic: Preparing for a second wave at a breast unit in northern Italy.

Ferro A, Cristofolini P, Garcia-Etienne CA, Caffo O, Pellegrini M, Fantò C, Mussari S, Campregher M, Lazzeri S, Cantarelli S, Guarrera GM. Ferro A, et al. Int J Health Plann Manage. 2021 Jul;36(4):1030-1037. doi: 10.1002/hpm.3181. Epub 2021 Apr 22. Int J Health Plann Manage. 2021. PMID: 33890324 Free PMC article.

2

Pain and quality of life after surgery for breast cancer.

Caffo O, Amichetti M, Ferro A, Lucenti A, Valduga F, Galligioni E. Caffo O, et al. Among authors: ferro a. Breast Cancer Res Treat. 2003 Jul;80(1):39-48. doi: 10.1023/A:1024435101619. Breast Cancer Res Treat. 2003. PMID: 12889597

3

Development and daily use of an electronic oncological patient record for the total management of cancer patients: 7 years' experience.

Galligioni E, Berloffa F, Caffo O, Tonazzolli G, Ambrosini G, Valduga F, Eccher C, Ferro A, Forti S. Galligioni E, et al. Among authors: ferro a. Ann Oncol. 2009 Feb;20(2):349-52. doi: 10.1093/annonc/mdn567. Epub 2008 Aug 20. Ann Oncol. 2009. PMID: 18718889 Free article.

4

Multicenter phase 2 study of combined gemcitabine and epirubicin as second-line treatment for patients with advanced ovarian cancer.

Murgia V, Sorio R, Griso C, Caffo O, Arcuri C, Ferro A, Caldara A, Scalone S, Arisi E, Galligioni E. Murgia V, et al. Among authors: ferro a. Int J Gynecol Cancer. 2010 Aug;20(6):953-7. doi: 10.1111/IGC.0b013e3181e4a6c1. Int J Gynecol Cancer. 2010. PMID: 20683401 Clinical Trial.

5

Multiple rechallenges for castration-resistant prostate cancer patients responding to first-line docetaxel: assessment of clinical outcomes and predictive factors.

Caffo O, Pappagallo G, Brugnara S, Caldara A, di Pasquale MC, Ferro A, Frisinghelli M, Murgia V, Russo LM, Soini B, Valduga F, Veccia A, Galligioni E. Caffo O, et al. Among authors: ferro a. Urology. 2012 Mar;79(3):644-9. doi: 10.1016/j.urology.2011.11.043. Urology. 2012. PMID: 22386418

6

Frequency of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from Trentino, North East Italy.

Giuliani S, Leonardi E, Aldovini D, Bernardi D, Pellegrini M, Soli F, Ferro A, Dalla Palma P, Decarli N, Barbareschi M. Giuliani S, et al. Among authors: ferro a. Pathologica. 2012 Jun;104(3):93-7. Pathologica. 2012. PMID: 22931039

7

In a cohort of breast cancer screened patients the proportion of HER2 positive cases is lower than that earlier reported and pathological characteristics differ between HER2 3+ and HER2 2+/Her2 amplified cases.

Giuliani S, Ciniselli CM, Leonardi E, Polla E, Decarli N, Luchini C, Cantaloni C, Gasperetti F, Cazzolli D, Berlanda G, Bernardi D, Pellegrini M, Triolo R, Ferro A, Verderio P, Barbareschi M. Giuliani S, et al. Among authors: ferro a. Virchows Arch. 2016 Jul;469(1):45-50. doi: 10.1007/s00428-016-1940-y. Epub 2016 Apr 21. Virchows Arch. 2016. PMID: 27097809

8

Weekly paclitaxel after first-line failure in patients with advanced non-small-cell lung cancer: everyday clinical practice in a single centre.

Dipasquale M, Murgia V, Veccia A, Brugnara S, Caldara A, Ferro A, Frisinghelli M, Maines F, Trentin C, Valduga F, Caffo O. Dipasquale M, et al. Among authors: ferro a. Anticancer Drugs. 2017 Jul;28(6):654-659. doi: 10.1097/CAD.0000000000000482. Anticancer Drugs. 2017. PMID: 28252532

9

Exploring metastatic breast cancer treatment changes during COVID-19 pandemic.

Fedele P, Ferro A, Sanna V, La Verde N, Paris I, Chiari R. Fedele P, et al. Among authors: ferro a. J Chemother. 2021 Jul;33(4):263-268. doi: 10.1080/1120009X.2020.1829328. Epub 2020 Oct 13. J Chemother. 2021. PMID: 33047649

10

Electronic Medical Record-Assisted Telephone Follow-Up of Breast Cancer Survivors During the COVID-19 Pandemic: A Single Institution Experience.

Merz V, Ferro A, Piras EM, Zanutto A, Caffo O, Messina C. Merz V, et al. Among authors: ferro a. JCO Oncol Pract. 2021 Jan;17(1):e44-e52. doi: 10.1200/OP.20.00643. Epub 2020 Dec 22. JCO Oncol Pract. 2021. PMID: 33351674

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,004 results

Search Page

Filters